Immune complex disease in a chronic monkey study with a humanised, therapeutic antibody against CCL20 is associated with complement-containing drug aggregates-Reference-Cited by-同舟云学术

Immune complex disease in a chronic monkey study with a humanised, therapeutic antibody against CCL20 is associated with complement-containing drug aggregates

Published:2020-04-23 Issue:4 Volume:15 Page:e0231655
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Laffan Susan B.,Thomson Andrew S.,Mai Shing,Fishman Cindy,Kambara Takahito,Nistala Kiran,Raymond James T.,Chen Shugui,Ramani Thulasi,Pageon Laura^ORCID,Polsky Rodd,Watkins Mark,Ottolangui Gemma,White John R.,Maier Curtis,Herdman Michael,Bouma Gerben^ORCID

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference28 articles.

1. Targeting chemokines: Pathogens can, why can’t we?;AE Proudfoot;Cytokine,2015

2. CCR6 expression defines regulatory effector/memory-like cells within the CD25(+)CD4+ T-cell subset;M Kleinewietfeld;Blood,2005

3. CC-chemokine receptor 6 is expressed on diverse memory subsets of T cells and determines responsiveness to macrophage inflammatory protein 3 alpha;F Liao;Journal of immunology,1999

4. Phenotypic and functional features of human Th17 cells;F Annunziato;The Journal of experimental medicine,2007

5. Regulation of CCR6 chemokine receptor expression and responsiveness to macrophage inflammatory protein-3alpha/CCL20 in human B cells;R Krzysiek;Blood,2000

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. T cell trafficking in human chronic inflammatory diseases;iScience;2024-08

2. Understanding the molecular mechanisms of anti-trafficking therapies and their clinical relevance in inflammatory bowel disease;Mucosal Immunology;2023-12

3. S100A4-neutralizing monoclonal antibody 6B12 counteracts the established experimental skin fibrosis induced by bleomycin;Rheumatology;2023-06-14

4. The respiratory system of the non-human primate;Spontaneous Pathology of the Laboratory Non-Human Primate;2023

5. Suppression of androgen receptor signaling induces prostate cancer migration via activation of the CCL20 – CCR6 axis;Cancer Science;2022-12-18